马疱疹病毒1型gB糖蛋白线性B细胞表位的预测与鉴定

试验旨在应用生物信息学技术综合分析马疱疹病毒1型（equine herpesvirus 1,EHV-1） gB糖蛋白,预测B细胞表位,筛选出具有潜在诊断价值的线性B细胞表位。将EHV-1 gB糖蛋白的基因序列输入DNAStar软件中的Protean工作区中,经参数综合比较分析筛选潜在的B细胞表位,克隆、表达预测表位的基因片段,利用表达的融合蛋白作为抗原与马疱疹病毒阳性血清反应。经预测分析,gB糖蛋白的B细胞表位可能位于第6-10、23-32、53-65、72-98、111-120、152-166和173-180位氨基酸区域。本试验成功构建并原核表达含7个潜在B细胞表位的融合蛋白。Western blotting试验结果显示,其中5个融合蛋白能被马疱疹病毒阳性血清识别。本试验利用生物信息学技术结合分子生物学技术成功筛选到5个潜在的B细胞表位,为EHV-1表位诊断、表位疫苗抗原的设计奠定了技术基础。     

Prediction and Identification of Linear B-cell Epitopes in gB Glycoprotein of Equine Herpesvirus Type 1

The study was aimed to predict B cell epitopes in gB glycoprotein of equine herpesvirus type 1 (EHV-1) with bioinformatics, and select epitopes which had potential diagnostic value. The DNA fragments of gB glycoprotein were predicted by protean of DNAStar software. Screening potential B cell epitopes after parameter comparison, the target B cell epitopes were selected, cloned and expressed. The expressed fusion proteins serviced as an antigen were used to react with equine herpesvirus positive serum to screen and identify antigenic epitopes. The results showed that according to predictive and analysis, the areas of amino acid from 6 to 10, 23 to 32, 53 to 65, 72 to 98, 111 to 120, 152 to 166, 173 to 180 might be gB glycoprotein B cell epitopes. Seven epitopes were successfully cloned into a prokaryotic expression vector, and confirmed by DNA sequencing. After expression and purification, Western blotting was performed to detect the antigen, which could be recognized by equine herpesvirus positive sera. Bioinformatics technology and molecular biology techniques were used to successfully screen five potential B cell epitopes, which provided the foundation for the diagnosis of EHV-1 and design of the epitope vaccine.     

Antigenic relationship among field isolates of Tritrichomonas foetus from cattle

Analysis of protein and antigen profiles of Tritrichomonas foetus isolates from cattle from 5 western states was accomplished by sodium dodecyl sulfate polyacrylamide-gel electrophoresis, immunoblot, immunoprecipitation, and fluorography techniques. Total protein profiles of all isolates were compared by Coomassie brilliant blue staining of T foetus protein samples prepared by 4 protein-extraction methods. Antigenic tritrichomonas proteins were identified by immunoblot assay with polyclonal bovine or rabbit anti-T foetus serum. Additionally, [14C]glucosamine-labeled T foetus was used for total and antigenic glycoprotein analyses. Detectable differences in the composition of total proteins or antigenic tritrichomonal proteins were not observed among all isolates. However, intensity differences in some antigenic protein bands were apparent. Bovine and rabbit sera from immunized animals possessed antibodies to the same antigenic tritrichomonal proteins. Each T foetus isolate contained 4 to 7 molecular weight size classes of glycoprotein, which were labeled by [14C]glucosamine; however, only 3 to 4 glycoproteins were identified as antigens by bovine or rabbit antiserum.     

The effect of antibody and complement on the expression of herpesvirus of bovine malignant catarrhal fever in cultured rabbit lymphocytes

Using indirect immunofluorescence with a hyperimmune calf serum, a virus-induced antigen was demonstrated on the surface of lymphocytes expressing intracellular malignant catarrhal fever virus antigens. Antibody to the antigen was also detected in terminal sera of both cattle and rabbits. Antisera did not restrict virus expression in explanted lymph nodes unless they were supplemented with two to four units of lytic complement per ml culture. While human, bovine and guinea pig complements caused immune lysis of infected lymphocytes, rabbit complement was ineffective. The relevance of the findings in the pathogenesis of the lymphoid proliferation caused by MCFV is discussed.     

Immunofluorescence with PI-3 virus--preparation and evaluation of conjugates from immune sera of various animal species]

Immune sera with a high content of antibodies to para-influenza-3 (PI-3) virus suitable for production of specific conjugated immunoglobulins were prepared on conventionally reared calves, rabbits, and guinea-pigs, applying antigen in different ways. When processing the sera of the above mentioned animal species to conjugates, the sera differed in pure IgG yield, in completed conjugate, and molar F/P ratios, but their ability to demonstrate antigens of the PI-3 virus in the dilution was approximately the same. The serum prepared on a colostrum deprived calf showed the lowest antibody content and the lowest pure IgG yield, the colouring ability of the conjugate prepared being as well somewhat lower.     

乙型脑炎病毒E蛋白抗原表位多肽序列鉴定及分析

为了对流行性乙型脑炎病毒(JEV)E蛋白抗原表位E19进行核心序列定位,本研究设计了一系列编码相互部分重叠短肽核苷酸序列,原核融合表达后经western blot分析,确定其抗原表位核心序列为150ENHGNYS156.该表位在乙型脑炎不同基因型的各种病毒株间为高度保守序列;根据JEV E19表位与同一血清群其他黄病毒之间的差异,在同源序列位置设计了系列突变短肽,融合表达后western blot分析的结果表明,其他黄病毒属病毒同源序列不能与抗JEV阳性血清反应.本实验结果表明JEV E蛋白抗原表位E19具有鉴别检测JEV与西尼罗病毒等其它黄病毒的意义.本实验为进一步研究E蛋白结构和功能以及建立乙型脑炎临床鉴别诊断方法奠定了分子生物学基础.     

Characterization of anti-idiotype reagents to bovine herpesvirus-1 monoclonal antibody

A monoclonal antibody (MAb) to a neutralization epitope on the 97-kD glycoprotein of bovine herpesvirus-1 (BHV-1) was used to prepare an anti-idiotypic antibody in rabbits. Purified F(ab')2 fragments of the MAb were used to immunize the animals and the sera containing the greatest anti-idiotype activity were identified by ELISA. After digestion of the immunoglobulins with pepsin and purification by affinity chromatography, anti-idiotype F(ab')2 fragments reacted specifically with the MAb in ELISA. Binding of the anti-idiotypic (anti-id) antibody was inhibited by preincubation of the MAb with BHV-1. Using an ELISA inhibition assay with BHV-1, the anti-id reagent inhibited the binding of anti-BHV-1 MAb to BHV-1, suggesting that the anti-id mimics an epitope of the 97-kD glycoprotein by binding the antigen combining site of the MAb. Development and characterization of this anti-id and future studies of its immunomodulatory effects are discussed.     

水貂阿留申病病毒CIEP抗原结合蛋白初探

以水貂阿留申病病毒对流免疫电泳(CIEP)细胞抗原为材料,经酶印迹(Westemblotting)测定,水貂阿留申病病毒CIEI细胞抗原与多克隆阳性血清反应,分子量为60000,50000和25000,而与CIEP阴性的抗水貂阿留申病病毒的单克隆抗体(Y—2—9)反应,分子量为60000,50000.因此初步确定水貂阿留申病病毒CIEP细胞抗原决定族位于分子25000蛋白上.     

Comparison of a radioimmunoprecipitation assay to immunoblotting and ELISA for detection of antibody to African swine fever virus

A radioimmunoprecipitation assay (RIPA) has been developed for detection of antibody to African swine fever virus (ASFV) and compared with the immunoblot assay with regard to sensitivity and specificity. Two hundred seven field sera, obtained from pigs in Spain from different geographic areas between 1975 and 1986, that were positive by ASFV enzyme-linked immunosorbent assay (ELISA) were also analysed by immunoblot assay and RIPA. By serum dilution experiments, the RIPA appeared at least as sensitive as the ELISA and immunoblotting tests, although ELISA and RIPA detected antibodies to ASFV earlier in natural infection than did the immunoblot assay, as disclosed by animal inoculation studies. The most antigenic ASFV-induced proteins in natural infection detected by RIPA were the viral proteins p243, p172, p73, p25.5, p15, and p12 and the infection proteins p30 and p23.5. In the immunoblot assay, the proteins that were most reactive with the same sera were the viral protein p25.5 and the infection proteins p30, p25, and p21.5. Only 1 serum, from an animal infected with ASFV, was negative by immunoblot assay but showed a positive result by RIPA. A modification of conventional RIPA was performed using a dot transference of immunoprecipitated proteins to a nitrocellulose filter. This modification simplified the conventional RIPA procedures by eliminating the electrophoresis of immunoprecipitated proteins without affecting sensitivity and specificity. The ease of use, specificity, and the sensitivity comparable to that of the immunoblot assay make the RIPA a useful confirmatory assay for sera that yield conflicting results in other ASFV antibody assays.     

Comparison of virologic and serologic responses of lambs and calves infected with bluetongue virus serotype 10

Four lambs and 3 calves, seronegative to bluetongue virus (BTV), were inoculated intravenously with a highly plaque-purified strain of BTV Serotype 10. A single calf and lamb served as controls and were inoculated with uninfected cell culture lysate. All BTV-inoculated lambs exhibited mild clinical manifestations of bluetongue, whereas infected calves were asymptomatic. Viremia persisted in BTV-infected lambs for 35-42 days, and for 42-56 days in BTV-infected calves. Neutralizing antibodies were first detected in sera collected at Day 14 post-inoculation (PI) from 2 BTV-infected calves and all 4 infected lambs, and at Day 28 PI in the remaining calf. The appearance of neutralizing antibody in serum did not coincide with clearance of virus from blood; BTV and specific neutralizing antibody coexisted in peripheral blood of infected lambs and calves for as long as 28 days. The sequential development, specificity and intensity of virus protein-specific humoral immune responses of lambs and calves were evaluated by immunoprecipitation of [35S]-labelled proteins in BTV-infected cell lysates by sera collected from inoculated animals at bi-weekly intervals PI. Sera from infected lambs and calves reacted most consistently with BTV structural proteins VP2 and VP7, and nonstructural protein NS2, and less consistently with structural protein VP5, and nonstructural protein NS1. Lambs developed humoral immune responses to individual BTV proteins more rapidly than calves, and one calf had especially weak virus protein-specific humoral immune responses; viremia persisted longer in this calf than any other animal in the study. The clearance of virus from the peripheral blood of BTV-infected lambs and calves is not caused simply by the production of virus-specific neutralizing antibody, however the intensity of humoral immune responses to individual BTV proteins might influence the duration of viremia in different animals.     

Enzyme-linked immunosorbent assay for differentiation of the antibody response of cattle naturally infected with Brucella abortus or vaccinated with strain 19

Purified O chain of Brucella abortus was passively attached to polystyrene to differentiate antibody responses of cattle vaccinated with B abortus strain 19 from those of naturally infected cattle. In the indirect assay, using O polysaccharide as antigen, a single serum dilution was used and mouse monoclonal antibody to bovine L chain conjugated with horseradish peroxidase was the detection reagent. Measurable antibody was not found in sera of vaccinated cattle, except for 3 sera from cattle that were persistently infected with strain 19. Sera from 25 cattle infected with pathogenic strains contained antibody on the basis of results of indirect enzyme immunoassay, using smooth lipopolysaccharide or O chain as antigens, or results of competitive enzyme immunoassay, using the O-chain antigen. Results in sera from calves with experimentally induced Yersinia enterocolitica serotype 0:9 infection or inoculated with a low dose of B abortus strain 2308 were comparable with those in sera of cattle that were vaccinated with strain 19. The data correlated with those from competitive enzyme immunoassay, using one serum dilution and horseradish peroxidase-conjugated mouse monoclonal antibody to smooth lipopolysaccharide. On the basis of results of the indirect enzyme immunoassay, all sera (except those samples obtained before inoculation) contained antibody to smooth lipopolysaccharide.     

Strains of bovine herpesvirus 1 that do not express an epitope on glycoprotein E in cell culture still induce antibodies that can be detected in a gE-blocking ELISA

Two bovine herpesvirus 1 (BHV1) field strains that do not express an epitope on glycoprotein E (gE) in cell culture were inoculated into calves to examine whether their sera became positive in a gE-blocking ELISA that detects antibodies against gE. This gE-blocking ELISA uses one monoclonal antibody that is directed against the above mentioned epitope. All calves, except one, infected with these gE-epitope negative BHV1 strains, became positive in this gE-blocking ELISA, about two weeks later than in another gE-ELISA and a gB-ELISA. However, cattle infected with BHVI strains that do express this particular gE-epitope showed a similar type of antibody responses. These findings demonstrate that BHV1 strains that do not express a particular gE-epitope in cell culture, still can induce antibodies that are detected in a blocking ELISA that measures antibodies against that epitope.     

Comparison of four serologic tests for the detection of antibodies to bovine leukemia virus

Four tests for detection of antibodies to bovine leukemia virus (BLV) were compared. The sera that were tested came from cattle in naturally infected commercial dairy herds, cattle that were infected under experimental conditions, and cattle in an isolated BLV-free herd. The tests that were compared included a radioimmunoprecipitation assay (RIA) with p24 antigen, a RIA with glycoprotein (gp) antigen, an agar-gel immunodiffusion (AGID) test with gp antigen, and a virus-neutralization (VN) test that was based on inhibition of BLV-induced syncytia in cell culture. Results of the 4 serologic tests agreed for 96.8% of the sera from cattle in commercial herds. The gp RIA detected the greatest number of positive sera (188); it was followed in turn by the p24 RIA (187), the VN test (183), and the AGID test (176). The gpd RIA titers of the 12 sera that gave negative AGID results were 175 or less. In RIA, the percentage of precipitation of labeled antigen by positive sera was almost always higher with gp antigen than with p24 antigen. Satisfactory sensitivity in the p24 RIA required the acceptance of a low level of antigen precipitation, 15%, as a positive test. In the gp RIA, however, almost all positive sera precipitated at least 50% of the labeled antigen. Nonspecific precipitation of antigen in the RIA by sera from BLV-free cattle ranged from 4% to 10%. Examination of sequential serum samples from 17 experimentally infected cattle showed that BLV antibody was first detected 2 to 8 weeks after inoculation. In 9 cattle, seroconversion was detected simultaneously by all of the tests. Results from the other 8 cattle indicated that seroconversion could be detected first by p24 RIA, followed by the gp RIA and the VN test. The longest interval between RIA seroconversion and AGID seroconversion was 10 days. Monthly tests of sera from 10 laboratory cattle that were infected by contact exposure showed that 7 animals seroconverted in all tests at the same time. Two cattle were positive first in RIA, but the next month they were also positive in the VN and AGID tests. One animal was positive in the RIA and the VN test for 2 months before antibody was detected by AGID.     

Genetic stability in calves of a single strain of bluetongue virus

Newborn calves were inoculated IV with highly plaque-purified bluetongue virus (BTV), serotype 10. The electrophoretic migration patterns of RNA segments and proteins of viruses isolated from calves at intervals after inoculation were compared. In addition, sera collected from calves at intervals after inoculation were compared for their abilities to neutralize several virus isolates from the same calf. Viremia persisted in calves for up to 56 days. Differences were not detected in the electrophoretic migration pattern of RNA segments or proteins of any of the BTV isolates. All calves produced high titers of neutralizing antibody to the original BTV inoculum by 28 days after inoculation, and significant (greater than or equal to 4-fold) differences were not detected in the neutralizing titers of sera to viruses collected at intervals after inoculation. The plaque-purified strain of BTV appeared to be stable genetically in infected calves, and failure to demonstrate antigenic variation among isolates indicated that antigenic shift was not the mechanism that allowed viremia to persist in BTV-infected calves.     

Canine C-reactive protein (CRP) does not share common antigenicity with human CRP

Differences in antigenicity between human and canine C-reactive proteins were investigated by Western blotting analysis. It was confirmed that several commercial anti-human CRP sera reacted with canine CRP. However, 34 anti-canine CRP sera prepared by immunization of rabbits and goats with canine CRP all reacted with canine CRP but not with human CRP in either immunoelectrophoresis or Western blotting.Immunization with human CRP produced a cross-reacting antibody that reacted with canine CRP. Conversely, immunization with canine CRP did not produce a cross-reacting antibody that reacted with human CRP. These findings may be interpreted as showing that, while canine and human CRPs do not share common antigenicity, they do contain structurally similar antigenic determinants.Abbreviations CRP C-reactive protein - PBS phosphate-buffered saline - SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis     

Characterisation of monoclonal antibodies to Epizootic Hemorrhagic Disease Virus of deer ( ) and Bluetongue Virus by immunisation of mice with recombinant VP7 antigen

Immunisation of mice with recombinant VP7 antigen of epizootic hemorrhagic disease virus of deer ( ) induced serum antibody responses to . However, from the 19 monoclonal antibodies (Mab) produced from these mice, 15 were specific for and four for bluetongue virus ( ). No Mabs were identified with the specificity for an epitope of VP7 shared by both and in spite of the fact that they share a large portion of homology in VP7 amino acids composition. These Mabs were divided into five groups based on their specificity and interaction with each other. Group II Mabs, consisting of 13 Mabs, recognises a potential serogroup specific, linear epitope of VP7 antigen. One of the Mabs to (Group V) was identified as VP7 specific with the possibility of being the serogroup specific and recognizes a potential conformational epitope. Two Mabs from these VP7 specific groups were further analysed and found to be useful in a competitive enzyme-linked immunosorbent assay ( - ) for detection of specific antibodies against and in bovine sera.     

猪圆环病毒2型衣壳蛋白优势B细胞表位重组蛋白免疫原性研究

猪圆环病毒2型(PCV-2)衣壳蛋白(Cap)是研制基因工程疫苗和血清抗体检测方法的主要候选抗原。为筛选免疫原性强的Cap抗原表位,将定位在Cap上的6个B细胞线性表位的编码基因序列重新组合,命名为R1234、R1235、R1236、R2345、R2346和R3456,然后克隆至pET32a原核表达载体,转化到大肠埃希菌中进行诱导表达。通过对表达和纯化条件的优化,最终获得6个多抗原表位串联体的重组蛋白。Western blot和间接ELISA结果显示,6组重组表位蛋白均能被PCV-2阳性血清特异性识别,具有良好的反应原性。将其与完整Cap分别免疫Balb/c小鼠,检测免疫后血清中特异性抗体和细胞因子水平以及脾脏淋巴细胞中CD4^+和CD8^+T淋巴细胞的比例。结果表明,R2346组合刺激机体产生的特异性抗体和细胞因子IFN-γ、IL-4的水平明显高于其他组,脾脏淋巴细胞中CD4^+和CD8^+T淋巴细胞含量与对照组相比显著增加(P<0.05),说明该重组蛋白能够刺激体液免疫和细胞免疫反应。因此,筛选获得的R2346重组表位蛋白可以作为研制PCV-2多表位基因工程疫苗和血清抗体诊断方法的候选抗原,用于PCV-2的预防和控制工作中。     

The use of 60Co-gamma ray-sterilized calf serum in cell culture

The use of 60Co-gamma-radiation-sterilised calf sera in cell culturing is reported in this paper. Evidence was produced to the effect that 60Co-gamma-irradiation, using a dosage of 3 kGy and a dose rate of 8 kGy/h, of fetal calf serum, neonatal calf serum, and calf serum did not substantially alter the growth-stimulating properties of those sera during 42-day tests. With almost all cell lines and sera used, for all practical purposes, they were identical with the properties of control sera. The following cell lines were used in the experimental programme: one human mammary tumor, MaTu, one human embryonic cell line--E VI, one bat lung cell line--Tb1-Lu, and one human rhabdomyosarcoma--A 204. Growth stimulation was twelve percent below the control value only with Tb1-Lu on Eagle-MEM culturing medium with 3-kGy-irradiation of neonatal calf serum. On the other hand, cell growth was stimulated by 28 percent in A 204 on RPMI 1640 culturing medium, again with 3-kGy-irradiation of neonatal calf serum. Loss of activity by up to 30 percent, depending on the serum used, must be expected from irradiation doses of 10 kGy and 20 kGy which are capable of causing drastic reduction or even complete elimination of serum-borne microorganisms (Bender et al., 1989). Sera irradiated that way would be only conditionally applicable, when it comes to highly vulnerable cell strains.     

Preparation and Preliminary Application of Highly Immunogenic Recombinant CD2v Antigen of African Swine Fever Virus

To obtain the highly immunogenic recombinant CD2v antigen of African swine fever virus (ASFV), the amino acid sequence of CD2v was analyzed for antigenic index using bioinformatics software and the intracytoplasmic region with high antigenic index was expressed in E. coli as an elastin-like polypeptide (ELP) fusion protein. After optimization of the conditions for inverse transition cycling (ITC), ELP-CD2v fusion protein was purified by ITC in the presence of different concentrations of Triton X-100 and the ELP tag was cleaved with active inclusion bodies of tobacco etch virus (TEV) protease. The tag-free recombinant CD2v antigen was recovered by an additional round of ITC and identified by Western blotting. By using the recombinant CD2v antigen, an indirect ELISA was established and used to detect ASFV antibody-positive and antibody-negative sera in parallel with the multi-antigen ELISA. The results showed that ELP-CD2v fusion protein was expressed correctly in E. coli with an optimal transition temperature of 28 ℃ at 1.5 mol·L^-1 NaCl. After one cycle of ITC in the presence of 0.2% Triton X-100, ELP-CD2v fusion protein was purified to 76.3% purity. The ELP tag was cleaved efficiently with the TEV protease and removed after an additional round of ITC. The recovered recombinant CD2v protein had a purity of 91.7%, which was recognized by pig anti-ASFV serum. For 30 serum samples detected by ASFV multi-antigen ELISA, recombinant CD2v ELISA showed that all of 15 antibody-negative sera were CD2v antibody negative and all of 15 antibody-positive sera were CD2v antibody positive. These data suggest that the presence of immune dominant epitopes in the intracytoplasmic region of CD2v protein and the potential application of the recombinant CD2v antigen for ASFV antibody detection.     

非洲猪瘟病毒强免疫原性重组CD2v抗原的制备与初步应用

旨在获得非洲猪瘟病毒（ASFV）强免疫原性重组CD2v抗原,利用生物信息学软件进行CD2v抗原指数分析,将其细胞质内免疫显性区与类弹性蛋白多肽（ELP）在重组大肠杆菌中进行融合表达,对ELP-CD2v融合蛋白的相变循环（ITC）条件进行优化,在优化条件下进行融合蛋白纯化,利用烟草蚀纹病毒（TEV）蛋白酶活性包涵体切除ELP标签,通过免疫转印法对重组CD2v抗原进行鉴定,利用重组CD2v抗原建立ELISA抗体检测方法,与多抗原ELISA对ASFV抗体阳性和阴性血清进行平行检测。结果显示,ELP-CD2v融合蛋白获得正确、可溶性表达,ITC条件为28℃和1.5 mol·L^-1 NaCl,在0.2% Triton X-100存在下进行ITC,纯化的融合蛋白纯度为76.3%;TEV蛋白酶活性包涵体能有效切割ELP标签,再次ITC回收的重组CD2v抗原纯度为91.7%,能被ASFV抗体识别;根据多抗原ELISA检测结果选择血清样品,用重组CD2v抗原ELISA进行检测,结果显示,15份ASFV抗体阴性血清均为CD2v抗体检测阴性,15份ASFV抗体阳性血清均为CD2v抗体检测阳性。这些研究结果表明,ASFV的CD2v蛋白胞内区存在强免疫原性表位,其重组抗原有望用于CD2v的抗体检测。